Evidence map›Paper›PMID 36629948›Full record

ArticleJournal of gastroenterology2023

Expert consensus on vaccination in patients with inflammatory bowel disease in Japan.

Takashi Ishige, Toshiaki Shimizu, Kenji Watanabe, Katsuhiro Arai, Koichi Kamei, Takahiro Kudo, Reiko Kunisaki, Daisuke Tokuhara, Makoto Naganuma, Tatsuki Mizuochi and 22 more

Erratum issuedOpen access · hybridAbstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2025
    Guideline
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 16 institutions in 1 country.

Takashi IshigeDepartment of Pediatrics, Gunma University Graduate School of Medicine, 3-39-22, Showa-Machi, Maebashi, Gunma, 371-8511, Japan. ishiget@gunma-u.ac.jp.ORCID 0000-0002-2409-7359
Toshiaki ShimizuDepartment of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kenji WatanabeDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, Japan.
Katsuhiro AraiDivision of Gastroenterology, Center for Pediatric Inflammatory Bowel Disease, National Center for Child Health and Development, Tokyo, Japan.
Koichi KameiDivision of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
Takahiro KudoDepartment of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan.
Reiko KunisakiInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Daisuke TokuharaDepartment of Pediatrics, Wakayama Medical University, Wakayama, Japan.
Makoto NaganumaDepartment of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan.
Tatsuki MizuochiDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Atsuko MurashimaCenter for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center of Child Health and Development, Tokyo, Japan.
Yuta InokiDivision of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
Naomi IwataDepartment of Infection and Immunology, Aichi Children's Health and Medical Center, Obu, Japan.
Itaru IwamaDivision of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.
Sachi KoinumaJapan Drug Information Institute in Pregnancy, National Center of Child Health and Development, Tokyo, Japan.
Hirotaka ShimizuDivision of Gastroenterology, Center for Pediatric Inflammatory Bowel Disease, National Center for Child Health and Development, Tokyo, Japan.
Keisuke JimboDepartment of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yugo TakakiDepartment of Pediatrics, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
Shohei TakahashiDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Yuki ChoDepartment of Pediatrics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Ryusuke NambuDivision of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.
Daisuke NishidaInflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Shin-Ichiro HagiwaraDepartment of Pediatric Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital, Osaka, Japan.
Norikatsu HikitaDepartment of Pediatrics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Hiroki FujikawaDivision of Gastroenterology, Center for Pediatric Inflammatory Bowel Disease, National Center for Child Health and Development, Tokyo, Japan.
Kenji HosoiDivision of Gastroenterology, Tokyo Metro Children's Medical Center, Tokyo, Japan.
Shuhei HosomiDepartment of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Yohei MikamiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Jun MiyoshiDepartment of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
Ryusuke YagiDepartment of Pediatrics, Gunma University Graduate School of Medicine, 3-39-22, Showa-Machi, Maebashi, Gunma, 371-8511, Japan.
Yoko YokoyamaDepartment of Intestinal Inflammation Research, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Tadakazu HisamatsuDepartment of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
National Center For Child Health and Development · JPJuntendo University · JPKyorin University · JPOsaka Metropolitan University · JPGunma University · JPSaitama Children's Medical Center · JPYokohama City University Medical Center · JPHyogo Medical University · JPHyogo University · JPJapanese Red Cross Kumamoto Hospital · JPKansai Medical University · JPKeio University · JPKurume University · JPOsaka Women's and Children's Hospital · JPTokyo Metropolitan Children's Medical Center · JPWakayama Medical University · JP

Funding

Ministry of Health, Labour and Welfare 20316729
6 · The paper itself

Abstract

Immunosuppressive therapies can affect the immune response to or safety of vaccination in patients with inflammatory bowel disease (IBD). The appropriateness of vaccination should be assessed prior to the initiation of IBD treatment because patients with IBD frequently undergo continuous treatment with immunosuppressive drugs. This consensus was developed to support the decision-making process regarding appropriate vaccination for pediatric and adult patients with IBD and physicians by providing critical information according to the published literature and expert consensus about vaccine-preventable diseases (VPDs) [excluding cervical cancer and coronavirus disease 2019 (COVID-19)] in Japan. This consensus includes 19 important clinical questions (CQs) on the following 4 topics: VPDs (6 CQs), live attenuated vaccines (2 CQs), inactivated vaccines (6 CQs), and vaccination for pregnancy, childbirth, and breastfeeding (5 CQs). These topics and CQs were selected under unified consensus by the members of a committee on intractable diseases with support by a Health and Labour Sciences Research Grant. Physicians should provide necessary information on VPDs to their patients with IBD and carefully manage these patients' IBD if various risk factors for the development or worsening of VPDs are present. This consensus will facilitate informed and shared decision-making in daily IBD clinical practice.

Indexed as

COVID-19Inflammatory Bowel DiseasesAdultChildConsensusFemaleHumansJapanPregnancyVaccinationCrohn’s diseaseImmunizationUlcerative colitisVaccine-preventable disease

Identifiers

PMID36629948
PMCPMC9838549
OpenAlexW4315573368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.